Cargando…
Metabolomic profiling for the identification of potential biomarkers involved in a laboratory azole resistance in Candida albicans
Candida albicans, one of the most common fungal pathogens, is responsible for several yeast infections in human hosts, being resistant to classically used antifungal drugs, such as azole drugs. Multifactorial and multistep alterations are involved in the azole resistance in Candida albicans. In this...
Autores principales: | Li, Ling, Liao, ZeBin, Yang, Yu, Lv, Lei, Cao, YingYing, Zhu, ZhenYu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796700/ https://www.ncbi.nlm.nih.gov/pubmed/29394282 http://dx.doi.org/10.1371/journal.pone.0192328 |
Ejemplares similares
-
Nicotinamide potentiates amphotericin B activity against Candida albicans
por: Yan, Yu, et al.
Publicado: (2022) -
Effect of Nicotinamide Against Candida albicans
por: Xing, XinRui, et al.
Publicado: (2019) -
Metabonomics on Candida albicans indicate the excessive H3K56ac is involved in the antifungal activity of Shikonin
por: Liao, ZeBin, et al.
Publicado: (2019) -
Endogenous nitric oxide accumulation is involved in the antifungal activity of Shikonin against Candida albicans
por: Liao, Zebin, et al.
Publicado: (2016) -
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)